The relationship between adrenocortical candidate gene expression and clinical response to hydrocortisone in patients with septic shock
Authors:
- 29 June 2021
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 47 (9) , 974-983
Abstract
Purpose To determine if adrenocortical gene expression is associated with clinical outcomes or response to corticosteroid treatment in septic shock. Methods A pre-specified nested cohort study of a randomised controlled trial of hydrocortisone compared to placebo in septic shock. Blood was collected for RNAseq analysis prior to treatment with hydrocortisone or placebo. The expression of adrenocortical candidate genes related to pituitary releasing hormones, mineralocorticoid and glucocorticoid receptors, intracellular glucocorticoid metabolism and transport proteins was measured. Results From May 2014 to April 2017, 671 patients were enrolled in the nested cohort study, from which 494 samples were available for analysis. We found no evidence of an association between candidate gene expression levels and either 90-day mortality, 28-day mortality or time to shock reversal. We observed evidence of a significant interaction between expression and treatment group for time to shock reversal in two genes; GLCCI1 (HR 3.81, 95%CI 0.57–25.47 vs. HR 0.64, 95%CI 0.13–3.07 for hydrocortisone and placebo respectively, p for interaction 0.008) and BHSD1 (HR 0.55, 95%CI 0.28–1.09 vs. HR 1.32 95%CI 0.67–2.60, p for interaction 0.01). Conclusions In patients with septic shock, there is no association between adrenocortical candidate gene expression and mortality. Patients with higher expression of GLCCI1 who received hydrocortisone achieved shock resolution faster than those receiving placebo; conversely, patients who had higher expression of BHSD1 who received hydrocortisone achieved shock resolution slower than those who received placebo. Variation in gene expression may be a mechanism for heterogeneity of treatment response to corticosteroids in septic shock.Keywords
Funding Information
- National Health and Medical Research Council (1004108, 1124926, 1085159)
This publication has 28 references indexed in Scilit:
- Septic serum induces glucocorticoid resistance and modifies the expression of glucocorticoid isoforms receptors: a prospective cohort study and in vitro experimental assayCritical Care, 2013
- Genetic variation in GLCCI1 and dexamethasone in bacterial meningitisJournal of Infection, 2012
- Corticosteroid resistance in sepsis is influenced by microRNA-124–induced downregulation of glucocorticoid receptor-α*Critical Care Medicine, 2012
- Validation of a gene expression-based subclassification strategy for pediatric septic shock*Critical Care Medicine, 2011
- Genomewide Association betweenGLCCI1and Response to Glucocorticoid Therapy in AsthmaNew England Journal of Medicine, 2011
- Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsisIntensive Care Medicine, 2009
- The functional roles of 11β-HSD1: vascular tissue, testis and brainMolecular and Cellular Endocrinology, 2003
- TNF‐α enhances intracellular glucocorticoid availabilityFEBS Letters, 2001
- Modulation of 11β-Hydroxysteroid Dehydrogenase Isozymes by Proinflammatory Cytokines in Osteoblasts: An Autocrine Switch from Glucocorticoid Inactivation to ActivationJournal of Bone and Mineral Research, 2001
- APACHE IICritical Care Medicine, 1985